Table 1.
Baseline patients’ demographic, clinical and hemodynamic characteristics at baseline. Data are presented as n(%), mean ± SD or median [Q1,Q3]
| Index | Valve (n = 144) |
|---|---|
| Baseline characteristics | |
| Age (years) | 67.3 ± 12.1 |
| Male | 81 (56.3%) |
| Weight (kg) | 72.3 ± 16.3 |
| Body Mass Index (kg/m2) | 26.8 ± 5.7 |
| Dialysis vintage (months) | 24.7 [15.2, 41.7] |
| Diabetes mellitus | 77, (53.5%) |
| Heart failure | 36, (25.0%) |
| Baseline hemodynamic parameters | |
| Systolic blood pressure (mmHg) | 139 ± 23 |
| Diastolic blood pressure (mmHg) | 70 ± 13 |
| Mean arterial pressure (mmHg) | 93 ± 15 |
| Heart rate (beats per minute) | 75 ± 12 |
| Stroke index (mL/m2) | 38.0 ± 11.3 |
| Cardiac index (L/min/m2) | 2.85 [2.13, 3.53] |
| Cardiac power index (W/m2) | 0.56 [0.42, 0.73] |
| Total peripheral resistance (dyn*sec/cm5*m2) | 2754 [2071,3398] |
| Baseline medications | n = 90 |
| Angiotensin converting enzyme inhibitor/ Angiotensin receptor binder | 42 (46.7%) |
| Calcium channel blocker | 48 (53.3%) |
| β receptor blocker | 53 (58.9%) |
| α receptor blocker | 15 (16.7%) |
| Insulin | 9 (10%) |
Data are presented as n(%), mean ± SD or median [Q1,Q3]